Author: admin

Understanding prescribing trends for hepatitis C treatment in Ontario

The introduction and wide availability of direct-acting antivirals (DAAs) as a treatment for hepatitis C through a phased rollout from 2015 to 2018 held the promise of expanded access to treatment. These simpler treatments carried fewer clinical restrictions and required less specialist support, opening the possibility for primary care providers to treat their patients with hepatitis C. Given barriers to healthcare access for people who use drugs, those of us at the Toronto Community Hep C Program were curious to find out if this had in fact happened.

Read more

Indigenous responses to COVID-19 and hepatitis: A conference report back

Viral hepatitis impacts Indigenous peoples around the world at much higher than average rates, harming their physical, spiritual, emotional, social and economic health. This is the result of historic and ongoing colonialism, and includes significantly worse health determinants, inadequate access to immunization and treatment, and inadequacies in the provision of culturally safe and responsive healthcare to Indigenous people. COVID-19 has further impacted Indigenous peoples, but many communities and healthcare practitioners are finding innovative ways of responding to the pandemic, while simultaneously trying to continue providing hepatitis care. Many of these responses were shared in a virtual mini-conference hosted by the...

Read more

What topics in the CATIE Blog were top of mind in 2020?

The year 2020 will leave an indelible mark on our collective consciousness: across the world, people are confronted with the novel coronavirus disease (COVID-19) and it seems to have consumed our lives. For many of us, not a day goes by that we don’t think about the virus, how it has altered our daily activities and what we need to do for our communities to remain healthy. Since the virus hit Canada in March 2020, service providers from across the country have mobilized to keep their clients safe and provide them the care and services they need to prevent, test...

Read more

Top HIV and hepatitis C stories of 2019

In 2019, we saw significant developments in the prevention, diagnosis and treatment of HIV and hepatitis C. We helped launch a blueprint for hepatitis C elimination in Canada. We witnessed innovation in HIV prevention and testing approaches, more people cured of hepatitis C, and “the London patient”, the second person cleared of HIV after discontinuing antiretroviral therapy. We also saw drawbacks. We continue to confront a devastating opioid overdose crisis driven by a poisoned drug supply, which claimed the lives of more than 2,000 Canadians in the first six months of the year alone.

Read more

INHSU 2019: Wholistic hepatitis C care, and the importance of care providers

Hundreds of clinicians, researchers and people with lived experience gathered in Montreal in September 2019 to highlight promising work in hepatitis C research and practice. The 8th International Conference on Hepatitis Care in Substance Users (INHSU 2019) showcased innovative models of care that support the delivery of hepatitis C treatment.

Read more

U=U and the overly-broad criminalization of HIV nondisclosure

By Nicholas Caivano and Sandra Ka Hon Chu People living with HIV in Canada have been charged with some of the most serious offences in the Criminal Code, even in cases of consensual sex where there was negligible or no risk of HIV transmission, no actual transmission and no intent to transmit. The Undetectable=Untransmittable (“U=U”) campaign is based on scientific research, including the ground-breaking PARTNER study, establishing that when a person living with HIV on treatment maintains an undetectable viral load for at least six months, the risk of transmitting the virus through sex is effectively non-existent. As advocates for...

Read more